Kim I Y, Schulam P G
Scott Department of Urology, Baylor College of Medicine, 6560 Fannin, Suite 2100, Houston, TX 77030, USA.
Curr Urol Rep. 2001 Feb;2(1):40-5. doi: 10.1007/s11934-001-0024-x.
Since the first reported case of laparoscopic nephrectomy by Clayman et al. in 1991, laparoscopy is gaining acceptance as a viable alternative to open surgery for renal cell carcinoma. The benefits of laparoscopy include improved quality of life and lower incidence of perioperative morbidity. The perceived risks of laparoscopic nephrectomy for renal cell carcinoma include port-site metastasis, increased operative time, and the concern for inadequate surgical resection. The preliminary data concerning laparoscopy in renal cell carcinoma, however, indicate that rates of tumor recurrence are equivalent to open surgery while resulting in better cosmesis, decreased level of perioperative analgesic use, and decreased length of time to full convalescence.
自1991年克莱曼等人首次报道腹腔镜肾切除术病例以来,腹腔镜手术作为肾细胞癌开放手术的一种可行替代方法正逐渐被接受。腹腔镜手术的益处包括生活质量提高和围手术期发病率降低。人们认为腹腔镜肾切除术治疗肾细胞癌存在的风险包括切口部位转移、手术时间延长以及对手术切除不充分的担忧。然而,有关肾细胞癌腹腔镜手术的初步数据表明,肿瘤复发率与开放手术相当,同时具有更好的美容效果、减少围手术期镇痛药物的使用量以及缩短完全康复所需的时间。